Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
PDS Biotechnology Corporation - Common Stock
(NQ:
PDSB
)
0.5853
+0.1862 (+46.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PDS Biotechnology Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
PDS BIOTECHNOLOGY CORP (NASDAQ:PDSB) Reports Narrower Q2 2025 Loss, Stock Rises on Clinical Progress
↗
August 13, 2025
PDS Biotechnology (PDSB) reported Q2 2025 EPS of -$0.21, beating estimates. Stock rose 8.13% pre-market as clinical progress, including ASCO presentations, boosts investor optimism. No revenue yet.
Via
Chartmill
PDSB Loss Improves as Costs Drop
↗
August 13, 2025
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
July 16, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
May 23, 2025
Via
Benzinga
Insights Ahead: PDS Biotechnology's Quarterly Earnings
↗
May 13, 2025
Via
Benzinga
A Look at PDS Biotechnology's Upcoming Earnings Report
↗
March 26, 2025
Via
Benzinga
Uncovering Potential: PDS Biotechnology's Earnings Preview
↗
November 13, 2024
Via
Benzinga
Earnings Preview For PDS Biotechnology
↗
March 26, 2024
Via
Benzinga
Earnings Scheduled For August 13, 2025
↗
August 13, 2025
Via
Benzinga
Insights into PDS Biotechnology's Upcoming Earnings
↗
August 12, 2025
Via
Benzinga
Earnings Scheduled For May 14, 2025
↗
May 14, 2025
Via
Benzinga
Analyst Expectations for PDS Biotechnology's Future
↗
November 15, 2023
Via
Benzinga
PDS Biotechnology Stock In Spotlight On Better-Than-Feared 2024 Loss – Retail Stays Bearish
↗
March 27, 2025
The company said the reduced losses were primarily due to decreased operating expenses.
Via
Stocktwits
Earnings Scheduled For March 27, 2025
↗
March 27, 2025
Via
Benzinga
PDS Biotechnology: Q3 Earnings Insights
↗
November 14, 2023
Via
Benzinga
A Preview Of PDS Biotechnology's Earnings
↗
November 13, 2023
Via
Benzinga
The Latest Analyst Ratings for PDS Biotechnology
↗
October 11, 2023
Via
Benzinga
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
March 14, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Life Sciences Investor Forum Agenda Announced for March 13th
March 12, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 14, 2024
Via
Benzinga
PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q2 2024
↗
August 13, 2024
PDSB stock results show that PDS Biotechnology beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q1 2024
↗
May 15, 2024
PDSB stock results show that PDS Biotechnology beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
March 27, 2024
Via
Benzinga
PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q4 2023
↗
March 27, 2024
PDSB stock results show that PDS Biotechnology beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For November 14, 2024
↗
November 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
March 27, 2024
Via
Benzinga
Earnings Scheduled For March 27, 2024
↗
March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.
Via
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in March 2024
↗
March 13, 2024
These 3 undervalued biotech stocks have been left behind so far but things could begin to turn around as we head into March.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
October 04, 2023
Via
Benzinga
Earnings Scheduled For August 14, 2023
↗
August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
